Skip to content

De Wase Apotheek: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

De Wase Apotheek

BE 0740.778.904
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€82,732
2024 · €85,290-€2,558
Equity
€480,000
2024 · €480,000
Cash
€72,614
2024 · €152,787-€80,174
Balance sheet total
€689,221
2024 · €726,080-€36,859

Largest movements

2024 to 2025
Assets
  • Cash -€80,174

    down €80,174 (-52.5%), from €152,787 to €72,614

    mainly Contributions, distributions and other (-€82,732) and Trade debts (-€48,542)

  • Stocks and contracts +€48,239

    up €48,239 (+28.5%), from €169,535 to €217,774

  • Intangible fixed assets -€48,000

    down €48,000 (-20.0%), from €240,132 to €192,132

  • Receivables within one year +€44,141

    up €44,141 (+29.4%), from €150,233 to €194,374

    of which Other amounts receivable: +€28,419

Equity and liabilities
  • Trade debts -€48,542

    down €48,542 (-33.5%), from €144,902 to €96,360

  • Tax, wage and social debts +€14,241

    up €14,241 (+90.1%), from €15,805 to €30,045

    of which Remuneration and social security: +€16,615

Income statement
  • Staff costs +€107,127

    up €107,127 (+110%), from €97,691 to €204,818

  • Gross operating margin +€79,523

    up €79,523 (+29.5%), from €269,943 to €349,467

  • Other operating charges -€21,393

    down €21,393 (-95.7%), from €22,343 to €950

  • Depreciation -€5,093

    down €5,093 (-9.3%), from €54,775 to €49,682

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €85,290
Gross operating margin +€79,523
Staff costs -€107,127
Depreciation +€5,093
Other operating charges +€21,393
Financial income -€1,816
Financial charges +€386
Taxes -€11
Result 2025 €82,732
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€2,558
Investment €0
Financing -€82,732
Cash 2024 €152,787
Net result for the year +€82,732
Depreciation +€49,682
Stocks and contracts -€48,239
Receivables within one year -€44,141
Deferred charges and accrued income -€617
Trade debts -€48,542
Tax, wage and social debts +€14,241
Other debts -€2,558
Contributions, distributions and other -€82,732
Cash 2025 €72,614
brings cash intakes cash out
Every line side by side 37 lines
Line Code 2024 2025 Change %
Total assets 20/58 €726,080 €689,221 -€36,859 -5.1%
Fixed assets 21/28 €248,659 €198,976 -€49,682 -20.0%
Intangible fixed assets 21 €240,132 €192,132 -€48,000 -20.0%
Tangible fixed assets 22/27 €8,527 €6,845 -€1,682 -19.7%
Plant, machinery and equipment 23 €8,527 €6,845 -€1,682 -19.7%
Current assets 29/58 €477,422 €490,245 +€12,823 +2.7%
Stocks and contracts in progress 3 €169,535 €217,774 +€48,239 +28.5%
Stocks 30/36 €169,535 €217,774 +€48,239 +28.5%
Amounts receivable within one year 40/41 €150,233 €194,374 +€44,141 +29.4%
Trade receivables 40 €105,589 €121,311 +€15,722 +14.9%
Other amounts receivable 41 €44,644 €73,063 +€28,419 +63.7%
Cash at bank and in hand 54/58 €152,787 €72,614 -€80,174 -52.5%
Deferred charges and accrued income 490/1 €4,866 €5,483 +€617 +12.7%
Total equity and liabilities 10/49 €726,080 €689,221 -€36,859 -5.1%
Equity 10/15 €480,000 €480,000 = 0.0%
Contributions 10/11 €480,000 €480,000 = 0.0%
Amounts payable 17/49 €246,080 €209,221 -€36,859 -15.0%
Amounts payable within one year 42/48 €246,080 €209,221 -€36,859 -15.0%
Trade debts 44 €144,902 €96,360 -€48,542 -33.5%
Suppliers 440/4 €144,902 €96,360 -€48,542 -33.5%
Taxes, remuneration and social security 45 €15,805 €30,045 +€14,241 +90.1%
Taxes 450/3 €4,692 €2,318 -€2,374 -50.6%
Remuneration and social security 454/9 €11,113 €27,728 +€16,615 +150%
Other amounts payable 47/48 €85,374 €82,816 -€2,558 -3.0%
Remuneration, social security and pensions 62 €97,691 €204,818 +€107,127 +110%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €54,775 €49,682 -€5,093 -9.3%
Other operating charges 640/8 €22,343 €950 -€21,393 -95.7%
Gross operating margin 9900 €269,943 €349,467 +€79,523 +29.5%
Operating profit (loss) 9901 €95,134 €94,017 -€1,117 -1.2%
Financial income 75/76B €23,058 €21,243 -€1,816 -7.9%
Recurring financial income 75 €23,058 €21,243 -€1,816 -7.9%
Financial charges 65/66B €3,735 €3,349 -€386 -10.3%
Recurring financial charges 65 €3,735 €3,349 -€386 -10.3%
Profit (loss) for the period before taxes 9903 €114,457 €111,910 -€2,547 -2.2%
Income taxes 67/77 €29,167 €29,179 +€11 0.0%
Profit (loss) for the period 9904 €85,290 €82,732 -€2,558 -3.0%
Profit (loss) for the period to be appropriated 9905 €85,290 €82,732 -€2,558 -3.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.